Authors:
Wasfy, MO
Oyofo, BA
David, JC
Ismail, TF
El-Gendy, AM
Mohran, ZS
Sultan, Y
Peruski, LF
Citation: Mo. Wasfy et al., Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt, J HEALTH PO, 18(1), 2000, pp. 33-38
Authors:
Scharrer, I
Brackmann, HH
Sultan, Y
Abshire, T
Gazengel, C
Ragni, M
Gorina, E
Vosburgh, E
Kellermann, E
Citation: I. Scharrer et al., Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A, HAEMOPHILIA, 6(6), 2000, pp. 614-618
Authors:
Molho, P
Rolland, N
Lebrun, T
Dirat, G
Courpied, JP
Croughs, T
Duprat, I
Sultan, Y
Citation: P. Molho et al., Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France, HAEMOPHILIA, 6(1), 2000, pp. 23-32
Authors:
Frenck, RW
Nakhla, I
Sultan, Y
Bassily, SB
Girgis, YF
David, J
Butler, TC
Girgis, NI
Morsy, M
Citation: Rw. Frenck et al., Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoidfever in children, CLIN INF D, 31(5), 2000, pp. 1134-1138
Authors:
Aillaud, MF
Morange, P
Juhan, I
Bauters, A
Jude, B
Biron-Andreani, C
Daures, JP
Schved, JF
Pernod, G
Polac, B
Bridey, F
De Prost, D
Borg, JY
Saladin-Theron, C
Le Cam, V
Denninger, MH
Truchaud, F
Trossaert, M
Boinot, C
Sultan, Y
Delahousse, B
Fimbel, B
Gruel, Y
Houbouyan, L
Bihour, C
Vergnes, C
Dutrillaux, F
Lorenzini, JL
Julia, A
Deschamps, A
Favier, R
Freyburger, G
Trzeciak, MC
Berruyer, M
Doumergue, G
Gris, JC
Toulon, P
Montpied, G
Marques-Verdier, A
Lequerrec, A
Guerin, V
Massignon, D
Citation: Mf. Aillaud et al., Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study, BL COAG FIB, 11(6), 2000, pp. 511-518
Authors:
Moreau, A
Lacroix-Desmazes, S
Stieltjes, N
Saenko, E
Kaveri, SV
D'Oiron, R
Sultan, Y
Scandella, D
Kazatchkine, MD
Citation: A. Moreau et al., Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophiliaA and in normal polyclonal human IgG, BLOOD, 95(11), 2000, pp. 3435-3441
Authors:
Batlle, J
Lopez, MF
Brackmann, HH
Gaillard, S
Goudemand, J
Humbert, J
De Moerloose, P
Maass, E
Mauz-Korholz, C
Sultan, Y
Stieltjes, N
Citation: J. Batlle et al., Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors, HAEMOPHILIA, 5(6), 1999, pp. 431-435
Authors:
Molho, P
Verrier, P
Stieltjes, N
Schacher, JM
Ounnoughene, N
Vassilieff, D
Menkes, CJ
Sultan, Y
Citation: P. Molho et al., A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis, HAEMOPHILIA, 5(2), 1999, pp. 115-123
Authors:
Lacroix-Desmazes, S
Moreau, A",Sooryanarayana,"Bonnemain, C
Stieltjes, N
Pashov, A
Sultan, Y
Hoebeke, J
Kazatchkine, MD
Kaveri, SV
Citation: S. Lacroix-desmazes et al., Catalytic activity of antibodies against factor VIII in patients with hemophilia A, NAT MED, 5(9), 1999, pp. 1044-1047
Authors:
Zini, JM
Durocher, A
Blettery, B
Fonlupt, J
Hofliger, P
Laurian, Y
Mangola, B
Roubertie, E
Sultan, Y
Vicariot, M
Delobel, J
Derlon, A
Ducluzeau, R
Fressinaud, E
Gaillard, S
Guerin, V
Guerois, C
Klotz, P
Lauroua, P
Lorenzini, JL
Murat, I
Oberling, F
Perrimond, H
Pierre-Louis, S
Pouzol, P
Richard, D
Rotschild, C
Simon, N
Subtil, E
Tron, P
Brucker, P
Cordier, H
Dindaine, ML
Citation: Jm. Zini et al., Emergency management of hemophiliacs with suspected hemorrhage, PRESSE MED, 28(11), 1999, pp. 591-595
Authors:
Parquet, A
Laurian, Y
Rothschild, C
Navarro, R
Guerois, C
Gay, V
Durin, A
Peynet, J
Sultan, Y
Citation: A. Parquet et al., Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate, THROMB HAEM, 82(4), 1999, pp. 1247-1249
Authors:
Girgis, NI
Butler, T
Frenck, RW
Sultan, Y
Brown, FM
Tribble, D
Khakhria, R
Citation: Ni. Girgis et al., Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance, ANTIM AG CH, 43(6), 1999, pp. 1441-1444
Authors:
Vastel, L
Courpied, JP
Sultan, Y
Kerboull, M
Citation: L. Vastel et al., Total knee replacement in hemophilia: consequences of HIV disease and postoperative deficient factor titer on results and complications, REV CHIR OR, 85(5), 1999, pp. 458-465
Authors:
Goudemand, J
Negrier, C
Ounnoughene, N
Sultan, Y
Citation: J. Goudemand et al., Clinical management of patients with von Willebrand's disease with a VHP vWF concentrate: the French experience, HAEMOPHILIA, 4, 1998, pp. 48-52